Lakeway, TX -- (SBWIRE) -- 02/14/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-
US Airways Group, Inc. (NYSE:LCC) shares gained 2.73% to $14.66. The boards of American Airlines parent AMR Corp. and US Airways Group Inc. separately voted to approve a merger that would create the world's largest airline, said people familiar with the matter.
US Airways Group Inc. Chief Executive Officer Doug Parker is closing in on a deal to combine with AMR Corp.’s American Airlines and form the world’s biggest carrier. Parker, 51, has applied lessons from his previous efforts, shifting tactics in pursuing the bankrupt AMR. The two companies are working on final details and their boards may vote on the deal later this week, people familiar with the matter have said today. Parker would lead the combined company, the people said.
How Should Investors Trade LCC After The Latest Earnings Report? Find Out Here
Catamaran Corp (USA) (NASDAQ:CTRX) shares increased 2.72% and closed at $53.59. The company announces that Jeff Park, Executive Vice President and Chief Financial Officer, will present at the Leerink Swann Global Healthcare Conference 2013 in New York City. Catamaran's presentation will take place on Wednesday, February 13, 2013, at 4:00 pm Eastern Standard Time.
Is CTRX a Buy After The Solid Earnings? Get Free Trend Analysis Here
Nu Skin Enterprises, Inc. (NYSE:NUS) stock increased 2.70% to $42.92. The company last week reported fourth-quarter net income of $59.23 million, or $0.97 per share, versus last year's $49.52 million, or $0.76 per share. Analysts expected earnings per share of $0.94 for the quarter. Revenue of $588.2 million for the quarter, were 19 percent higher than $495.3 million in the prior-year period. Analysts estimated revenues of $579.50 million for the quarter.
How Should Investors Trade NUS After The Recent Movement? Find Out Here
Delcath Systems, Inc. (NASDAQ:DCTH) shares gained 2.65% to $1.55. The company, on Feb. 4, announced that the Institut für das Entgeltsystem im Krankenhaus (InEk), the German federal reimbursement agency, has established a reimbursement pathway for the treatment of patients with liver metastases with the Delcath Hepatic CHEMOSAT® Delivery System for melphalan hydrochloride. The decision by the InEK followed an endorsement by the German Radiology Association, which prompted 47 cancer centers throughout Germany to submit applications under the Neue Untersuchungs- und Behandlungsmethoden (NUB) scheme for new technology reimbursement at specific hospitals.
Get Latest News, Updates and Reports For Free On DCTH Here
Best Damn Penny Stocks’ team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.
The assembled information disseminated by Bestdamnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bestdamnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in Bestdamnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)